U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07944378) titled 'A Study Evaluating the Safety and Effectiveness of Lokelma in Indian Patients With Hyperkalaemia' on Nov. 03.
Brief Summary: This is a Phase IV, multicentre, open-label, non-comparative study evaluating Lokelma (sodium zirconium cyclosilicate, SZC) in approximately 100 Indian adults with mild to moderate hyperkalaemia.
Study Start Date: Aug. 08
Study Type: INTERVENTIONAL
Condition:
Hyperkalemia
Intervention:
DRUG: Lokelma
Sodium Zirconium Cyclosilicate SZC Lokelma 5g and 10 g
Recruitment Status: RECRUITING
Sponsor: AstraZeneca
Published by HT Digital Content Services with permission from Health Daily Digest....